{
  "meta": {
    "title": "92_Acute_Leukemia",
    "url": "https://brainandscalpel.vercel.app/92-acute-leukemia-003b8671.html",
    "scrapedAt": "2025-11-30T12:29:17.666Z"
  },
  "questions": [
    {
      "text": "What is the most common type of leukemia in adults?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Adult acute lymphoblastic leukemia"
        },
        {
          "id": 3,
          "text": "Chronic myeloid leukemia"
        },
        {
          "id": 4,
          "text": "Chronic lymphoid leukemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Chronic lymphoid leukemia&nbsp;(<strong>CLL</strong>) is the most common type of leukemia in <strong>adults</strong>.</p>\n<p>The common types of leukemia in various age groups is as follows:</p>\n<ul>\n<li>Acute myeloid leukemia (<strong>AML</strong>) - most common <strong>acute leukemia</strong> in adults</li>\n<li>Acute lymphoid leukemia (<strong>ALL</strong>) - most common cancer in <strong>childhood.&nbsp;</strong>The most common subtype of ALL is&nbsp;<strong>B-cell</strong> ALL</li>\n<li>Non-Hodgkin's lymphoma (<strong>NHL</strong>) - most common<strong> lymphoid </strong>malignancy in<strong> adults</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2027",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is not a risk factor for acute myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "Down's syndrome"
        },
        {
          "id": 2,
          "text": "Bloom syndrome"
        },
        {
          "id": 3,
          "text": "Fanconi anemia"
        },
        {
          "id": 4,
          "text": "Evan's syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Evan's syndrome does not predispose to acute&nbsp;myeloid leukemia (<strong>AML</strong>).</p>\n<p>The following conditions predispose to AML:</p>\n<p><strong>Genetic conditions:</strong></p>\n<ul>\n<li><strong>Down's syndrome</strong>:\n<ul>\n<li>Young children &lt;4 years</li>\n<li>Typically of the acute megakaryocytic subtype and associated with GATA1 mutations</li>\n<li>Excellent clinical outcomes&nbsp;</li>\n</ul>\n</li>\n<li>Defective DNA repair in conditions like&nbsp;ataxia telangiectasia,<strong> Fanconi anemia,&nbsp;</strong>and<strong> Bloom syndrome</strong>&nbsp;</li>\n</ul>\n<p><strong>Environmental factors:</strong></p>\n<ul>\n<li>Drugs:&nbsp;\n<ul>\n<li>Alkylating agents<strong> - c</strong>yclophosphamide, melphalan, dacarbazine, platinum compounds, after 4-6 years of exposure</li>\n<li>Topoisomerase II inhibitors <strong>-</strong> etoposide, after 1-3 years of exposure.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Radiation - high dose radiation, therapeutic radiation in patients exposed to alkylating agents</li>\n<li>Chemicals - benzene, petroleum products, pesticide</li>\n</ul>\n<p><strong>Hematological disorders with increased risk of AML:</strong></p>\n<ul>\n<li>Myeloproliferative disorders</li>\n<li>Paroxysmal nocturnal hemoglobinuria</li>\n<li>Aplastic anemia</li>\n<li>Myelodysplastic syndrome</li>\n<li>Multiple myeloma</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2034",
      "difficulty": "easy"
    },
    {
      "text": "A 2-year-old girl was referred with recurrent bacterial infections. Parents report that their first child also had similar features and died at the age of 18 months from myeloid leukemia. Investigations revealed markedly reduced absolute neutrophil count. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Bloom syndrome"
        },
        {
          "id": 2,
          "text": "Kostmann disease"
        },
        {
          "id": 3,
          "text": "Diamond-Blackfan syndrome"
        },
        {
          "id": 4,
          "text": "Chediak-Higashi syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario of <strong>congenital neutropenia</strong>&nbsp;is suggestive of <strong>Kostmann syndrome</strong>. It is associated with an increased risk of acute myeloid leukemia (<strong>AML</strong>).</p>\n<p>Kostmann syndrome occurs due to mutations in<strong>&nbsp;</strong>the <strong>G-CSF receptor</strong> and neutrophil elastase. This causes bone marrow failure specifically in the myeloid lineage. It presents in young children as <strong>recurrent</strong> <strong>bacterial</strong> <strong>infections</strong> (such as otitis media, cellulitis) and oral ulcers.&nbsp;</p>\n<p>Option A: Bloom syndrome occurs due to defects in DNA repair.&nbsp;It is not associated with neutropenia but has a higher risk of AML.&nbsp;</p>\n<p>Option C: Diamond-Blackfan syndrome refers to congenital erythroid aplasia. It is also associated with a higher risk of AML.&nbsp;</p>\n<p>Option D: Chediak-Higashi syndrome is due to defective phagolysosome formation. It is not associated with neutropenia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4236",
      "difficulty": "hard"
    },
    {
      "text": "A 60-year-old man is being evaluated for suspected acute myeloid leukemia. He reports a fast-growing swelling in his mouth for the past 1 week. On examination, there is a greenish gingival mass with a necrotic surface. This presentation is likely associated with which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "AML M2"
        },
        {
          "id": 2,
          "text": "AML M3"
        },
        {
          "id": 3,
          "text": "AML M7"
        },
        {
          "id": 4,
          "text": "AML M5a"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical scenario is suggestive of a <strong>chloroma</strong>. It is commonly associated with the<strong>&nbsp;M2</strong>&nbsp;subtype of acute myeloid leukemia, also called <strong>AML with maturation</strong>.</p>\n<p>Chloroma is also called<strong>&nbsp;myeloid sarcoma</strong>, extramedullary myeloid tumor, or granulocytic sarcoma. It is an extramedullary tumor mass consisting of myeloid blasts, with or without maturation<strong>. </strong>It is called chloroma due to the peculiar <strong>green color</strong>, caused by <strong>myeloperoxidase</strong>.&nbsp;The sites affected include&nbsp;<strong>orbit</strong> (most common), skull, oral cavity, paranasal sinuses, sternum, ribs, vertebrae, and pelvis.</p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3648",
      "difficulty": "medium"
    },
    {
      "text": "Patients suffering from which type of AML are more prone to develop disseminated intravascular coagulation?",
      "choices": [
        {
          "id": 1,
          "text": "Monocytic"
        },
        {
          "id": 2,
          "text": "Myelomonocytic"
        },
        {
          "id": 3,
          "text": "Monoblastic"
        },
        {
          "id": 4,
          "text": "Acute promyelocytic"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Disseminated intravascular coagulation (<strong>DIC</strong>) is commonly seen&nbsp;in patients with acute promyelocytic leukemia (<strong>APL</strong>).</p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4258",
      "difficulty": "medium"
    },
    {
      "text": "Oral cavity examination of a 56-year-old man with suspected leukemia revealed the following. What subtype of AML is he likely to be suffering from?",
      "choices": [
        {
          "id": 1,
          "text": "M7"
        },
        {
          "id": 2,
          "text": "M5"
        },
        {
          "id": 3,
          "text": "M3"
        },
        {
          "id": 4,
          "text": "M2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows swollen and spongy gums, indicating <strong>gum infiltration</strong>. This is a characteristic feature of acute monocytic leukemia (<strong>AML-M5</strong>).</p>\n<p>Infiltration of the gingivae, skin, soft tissues or meninges with leukemic blasts is characteristic of the monocytic subtypes and those with 11q23 chromosomal abnormalities.</p>\n<p>Less commonly, infiltration is also seen in acute myelomonocytic leukemia (<strong>AML-M4</strong>).</p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b9a5857597db45929ff7e63d72113b3d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2246",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following would be seen on flow cytometry of a patient with acute megakaryoblastic leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "CD113"
        },
        {
          "id": 2,
          "text": "CD 117"
        },
        {
          "id": 3,
          "text": "CD 61"
        },
        {
          "id": 4,
          "text": "CD 13"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>On flow cytometry, the immunophenotype of <strong>acute megakaryoblastic leukemia</strong> is <strong>CD41</strong> and/or <strong>CD61</strong>&nbsp;positive (platelet-specific antigens).</p>\n<p>Flow cytometry is useful in establishing the different subtypes of AML:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Phenotype</strong></td>\n<td><strong>CD markers</strong></td>\n</tr>\n<tr>\n<td>Myeloblastic</td>\n<td>CD11b,13,33,117</td>\n</tr>\n<tr>\n<td>Promyelocytic(M3)</td>\n<td>CD13,33</td>\n</tr>\n<tr>\n<td>Myelomonocytic(M4)</td>\n<td>CD11b,13,14,33</td>\n</tr>\n<tr>\n<td>Monocytic(M5)</td>\n<td>CD11b,11c,13,14,33&nbsp;</td>\n</tr>\n<tr>\n<td>Erythroid(M6)</td>\n<td>Glycophorin,spectrin</td>\n</tr>\n<tr>\n<td>Megakaryoblastic(M7)</td>\n<td>CD41,61</td>\n</tr>\n<tr>\n<td>Basophilic</td>\n<td>CD11,13,33,123</td>\n</tr>\n<tr>\n<td>Mast cell</td>\n<td>CD13,33,117</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4238",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about the WHO classification of acute myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "The clinical features are not considered to define the subtype"
        },
        {
          "id": 2,
          "text": "The cutoff value of blast cells for diagnosis is 20%"
        },
        {
          "id": 3,
          "text": "It is only based on morphological features of myeloid precursors"
        },
        {
          "id": 4,
          "text": "Chromosomal translocations along with > 20% blasts are needed for diagnosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The cutoff value of <strong>blast cells</strong> for the diagnosis of <strong>AML</strong> is <strong>20%</strong> according to the <strong>WHO</strong> classification.&nbsp;This classification is based on the&nbsp;<strong>clinical features, cytogenetic </strong>and<strong> molecular</strong> abnormalities in addition to <strong>morphology</strong>. This is in contrast to the&nbsp;previously used French-American-British (<strong>FAB</strong>) classification&nbsp;which was based on&nbsp;<strong>only</strong>&nbsp;<strong>morphology</strong> of myeloid precursors.</p>\n<p>The major changes in the WHO classification in contrast to FAB classification are:</p>\n<ul>\n<li>Blast cutoff for diagnosis of AML is <strong>20%</strong> (30% in FAB classification)&nbsp;</li>\n<li>Specific <strong>chromosomal rearrangements</strong>&nbsp;such as&nbsp;t (8;21), inv(16), t(16;16) and t (15;17) can define AML even with<strong> &lt; 20% blasts</strong>&nbsp;</li>\n<li><strong>Immunophenotyping</strong> (flow cytometry) is used to differentiate AML from ALL and to identify some subtypes of AML&nbsp;</li>\n<li>Myeloid dysplasia with blasts between 20-30% can benefit from therapy for myelodysplastic syndrome (decitabine, 5-azacytidine, cedazuridine)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2088",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man is referred for evaluation of severe anemia, persistent fever, and recurrent epistaxis. Lab investigations are given below. What is the diagnosis?<div class='question-desc-html'><p>Hb = 6 g/dL</p>\n<p>Total WBC count - 40,000/ mm<sup>3</sup></p>\n<p>Platelet count - 12,000/cu.mm</p>\n<p>Bone marrow - 10% blasts, positive for t(8;21) translocation</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute lymphoblastic leukemia"
        },
        {
          "id": 2,
          "text": "Acute myeloblastic leukemia"
        },
        {
          "id": 3,
          "text": "Preleukemia"
        },
        {
          "id": 4,
          "text": "Aleukemic leukemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>acute myeloblastic leukemia</strong> (AML).</p>\n<p>According to the <strong>WHO criteria</strong>, the diagnosis of AML requires any<strong> one </strong>of the following:</p>\n<ul>\n<li>Blast cell count ≥20% either in the peripheral blood or bone marrow</li>\n<li><strong>Presence</strong> of any one of the following <strong>cytogenetic abnormalities</strong>:\n<ul>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">t(15;17) </li>\n<li>t(8;21) </li>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Inversion 16 or t(16;16)</li>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">t(9;22)</li>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">NPM1 mutation (Nucleophosmin mutation)</li>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">CEBPA mutation</li>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">FLT3-ITD</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0515",
      "difficulty": "easy"
    },
    {
      "text": "Patients with all of the following are classified as AML with recurrent cytogenetic abnormalities except:",
      "choices": [
        {
          "id": 1,
          "text": "t(16,16)"
        },
        {
          "id": 2,
          "text": "NPM1 mutation"
        },
        {
          "id": 3,
          "text": "CEBPA mutation"
        },
        {
          "id": 4,
          "text": "t(9,22)"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The chromosomal translocation <strong>t(9,22)</strong> is called the Philadelphia chromosome. It is seen in patients with <strong>CML</strong>.</p>\n<p>AML with recurrent genetic abnormalities includes the following chromosomal aberrations:</p>\n<ul>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">t(15;17)&nbsp;</li>\n<li>t(8;21)&nbsp;</li>\n<li data-leveltext=\"%1)\" data-font=\"\" data-listid=\"17\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Inversion 16&nbsp;or<strong>&nbsp;t(16;16)</strong></li>\n</ul>\n<p>Two gene mutations have been added to the&nbsp;criteria of AML with recurrent genetic abnormalities in addition to chromosomal aberrations.&nbsp;Both gene mutations are associated with a&nbsp;<strong>good prognosis.</strong></p>\n<ul>\n<li><strong>NPM1</strong> mutation: Nucleophosmin mutation</li>\n<li><strong>CEBPA</strong> mutation</li>\n</ul><hr><h3>Related Pearl: Important Translocations in AML</h3><table>\n<tbody>\n<tr>\n<td>Translocation</td>\n<td>t(8,21)\n<p>(most common)&nbsp;</p>\n</td>\n<td>t(15,17)</td>\n<td>t(16,16) or inv(16)</td>\n</tr>\n<tr>\n<td>Fusion gene</td>\n<td>\n<p>RUNX1-RUNX1T1</p>\n</td>\n<td>PML-RAR&alpha;</td>\n<td>CBF-&beta; (Core binding factor)</td>\n</tr>\n<tr>\n<td>FAB classification</td>\n<td>\n<p>Blasts with maturation/M2</p>\n</td>\n<td>Acute promyelocytic leukemia/M3</td>\n<td>Myelomonocytic/M4</td>\n</tr>\n<tr>\n<td>Clinical association</td>\n<td>Myeloid sarcoma/ chloroma</td>\n<td>DIC</td>\n<td>Eosinophilia</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Very good</td>\n<td>Good</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2136",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following cytogenetic abnormalities is seen in patients with acute promyelocytic leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "t(15;17)"
        },
        {
          "id": 2,
          "text": "t(16;16)"
        },
        {
          "id": 3,
          "text": "RUNX1-RUNX1T1"
        },
        {
          "id": 4,
          "text": "CBF-β mutation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>t(15,17)</strong> is associated with acute promyelocytic leukemia (<strong>APL</strong>).</p><hr><h3>Related Pearl: Important Translocations in AML</h3><table>\n<tbody>\n<tr>\n<td>Translocation</td>\n<td>t(8,21)\n<p>(most common)&nbsp;</p>\n</td>\n<td>t(15,17)</td>\n<td>t(16,16) or inv(16)</td>\n</tr>\n<tr>\n<td>Fusion gene</td>\n<td>\n<p>RUNX1-RUNX1T1</p>\n</td>\n<td>PML-RAR&alpha;</td>\n<td>CBF-&beta; (Core binding factor)</td>\n</tr>\n<tr>\n<td>FAB classification</td>\n<td>\n<p>Blasts with maturation/M2</p>\n</td>\n<td>Acute promyelocytic leukemia/M3</td>\n<td>Myelomonocytic/M4</td>\n</tr>\n<tr>\n<td>Clinical association</td>\n<td>Myeloid sarcoma/ chloroma</td>\n<td>DIC</td>\n<td>Eosinophilia</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Very good</td>\n<td>Good</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4239",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old woman presented with fatigue and fever for the past 2 months. Investigations revealed pancytopenia and the following peripheral smear findings. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "AML"
        },
        {
          "id": 2,
          "text": "ALL"
        },
        {
          "id": 3,
          "text": "CML"
        },
        {
          "id": 4,
          "text": "CLL"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and peripheral smear showing blast cells with<strong> peroxidase granules</strong>&nbsp;are suggestive of acute myeloid leukemia (<strong>AML</strong>).&nbsp;Peroxidase granules are <strong>dark blue-stained</strong> granules seen in the cytoplasm on peroxidase staining.&nbsp;</p>\n<p>Myeloperoxidase cytochemical activity is negative in&nbsp;chronic myeloid leukemia&nbsp;(CML) and blast crisis.</p><hr><h3>Related Pearl: Cytochemistry of Acute Leukemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>AML</strong></td>\n<td><strong>ALL</strong></td>\n</tr>\n<tr>\n<td>Myeloperoxidase</td>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Sudan black</td>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Non-specific esterase</td>\n<td>\n<p>Strongly +ve: M4, M5</p>\n<p>Weakly +ve: M3, M7</p>\n</td>\n<td>_</td>\n</tr>\n<tr>\n<td>Periodic acid Schiff</td>\n<td>+ve in AML M6</td>\n<td>+</td>\n</tr>\n<tr>\n<td>Acid phosphatase</td>\n<td>-</td>\n<td>+ (T-cell)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/1de3afe66ebb411baf86ba59f5c91a55.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4251",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following patients with AML has a better prognosis than the others?",
      "choices": [
        {
          "id": 1,
          "text": "A 48-year-old man newly diagnosed with AML with a family history of lymphoma"
        },
        {
          "id": 2,
          "text": "A 60-year-old woman who developed AML following chemotherapy for ovarian cancer"
        },
        {
          "id": 3,
          "text": "A 71-year-old man with a longstanding history of myelodysplastic syndrome"
        },
        {
          "id": 4,
          "text": "A 67-year-old woman evaluated with a 4-month history of pancytopenia prior to diagnosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Young age</strong> of onset is associated with a <strong>good prognosis</strong> in patients with AML. Family history does not affect the prognosis.</p>\n<p>Poor prognosis is seen in the following cases:</p>\n<ul>\n<li><strong>Advancing age</strong> (usually defined as <strong>&gt; 60 years</strong>)&nbsp;</li>\n<li>Previous hematologic disorders - myeloproliferative neoplasms and&nbsp;<strong>myelodysplastic</strong> syndrome</li>\n<li>Longstanding <strong>cytopenias &gt;3 months</strong> before diagnosis&nbsp;</li>\n<li>Therapy-related AML (<strong>chemotherapy</strong> for other cancers)</li>\n<li>Chromosomal aberrations with poor outcomes</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4248",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist is examining the peripheral smear of a patient with suspected leukemia. All of the following features are suggestive of a myeloblast except:",
      "choices": [
        {
          "id": 1,
          "text": "Auer rods"
        },
        {
          "id": 2,
          "text": "Prominent nucleoli"
        },
        {
          "id": 3,
          "text": "Phi bodies"
        },
        {
          "id": 4,
          "text": "Pelger-Huet anomaly"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Pelger-Huet anomaly is not a feature of myeloblasts.&nbsp;<strong>Auer rods</strong> and <strong>Phi bodies</strong> are considered <strong>pathognomonic</strong> of <strong>AML.</strong></p>\n<p>Myeloblasts have the following characteristics as shown in the following image:</p>\n<ul>\n<li>Large, uniform population of cells</li>\n<li><strong>Prominent nucleoli</strong> (yellow arrow in the image)</li>\n<li>Primary cytoplasmic granules</li>\n<li><strong>Auer rods -</strong>&nbsp;needle-shaped azurophilic intracytoplasmic inclusion bodies formed by fusion of lysosomes (black arrow)</li>\n<li><strong>Phi-bodies -</strong>&nbsp;fusiform or spindle-shaped rods similar to Auer rods that require special stains for hydroperoxidases</li>\n<li>Pseudo-Chediak-Higashi syndrome - Giant lysosomes forming intracytoplasmic inclusion bodies</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb2d4b735e274611a79fe8ed2d02baa9x1064x1634.JPEG\" alt=\"Explanation Image\"><p><strong>Pelger-Huet</strong> anomaly refers to neutrophils with <strong>bilobed nuclei</strong> that occur as a benign, inherited condition. <strong>Pseudo-Pelger-Huet</strong> anomaly refers to an acquired defect seen in <strong>CML</strong>, <strong>myelodysplastic</strong> syndrome.&nbsp;</p>\n<p>Note: Chediak-Higashi syndrome is a rare autosomal recessive disorder with abnormal lysosomal trafficking (LYST gene). Presents with oculocutaneous albinism and immunodeficiency.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2144",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to the ER with a sudden-onset fever and the following painful rash over her face and upper limbs. CBC reveals neutrophilia. This presentation is associated with all of the following conditions except:",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Crohn's disease"
        },
        {
          "id": 3,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 4,
          "text": "Aplastic anemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This clinical presentation with painful edematous plaques is suggestive of <strong>febrile neutrophilic dermatosis</strong> or <strong>Sweet syndrome</strong>. It is not associated with aplastic anemia. It is associated with the following conditions:</p>\n<ul>\n<li>Acute myeloid leukemia (<strong>AML</strong>) - most common</li>\n<li>Inflammatory bowel disease (<strong>IBD</strong>)</li>\n<li>Solid malignancies of the genitourinary tract</li>\n<li>Systemic lupus erythematosus (<strong>SLE</strong>)</li>\n<li>Drugs - all-trans-retinoic acid, granulocyte colony-stimulating factor (G-CSF)</li>\n<li>Idiopathic Sweet syndrome - common in women following respiratory tract infection</li>\n</ul>\n<p>This condition presents with the following triad:</p>\n<ul>\n<li>Fever</li>\n<li>Neutrophilia</li>\n<li>Dense dermal infiltrate of neutrophils:&nbsp;\n<ul>\n<li><strong>Pinkish-red</strong> to reddish-brown edematous <strong>painful</strong> plaques</li>\n<li>Occur over the head, neck, extremities</li>\n</ul>\n</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/90fc36735ada43a1ac4e06c99141b0a7.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2141",
      "difficulty": "medium"
    },
    {
      "text": "What is the most commonly used complete remission induction regimen in patients with AML?",
      "choices": [
        {
          "id": 1,
          "text": "All-trans-retinoic acid and arsenic trioxide"
        },
        {
          "id": 2,
          "text": "L- asparginase"
        },
        {
          "id": 3,
          "text": "Cytarabine with anthracyclines"
        },
        {
          "id": 4,
          "text": "Cytarabine with alkylating agents"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most commonly used complete remission induction regimen in patients with <strong>AML</strong> is <strong>cytarabine</strong> and an <strong>anthracycline</strong> (e.g., daunorubicin, idarubicin).</p>\n<p>The treatment of AML is as follows:</p>\n<ul>\n<li><strong>Induction </strong>chemotherapy with a 7+3 regimen:<strong> </strong>\n<ul>\n<li>Cytarabine - continuous intravenous infusion for <strong>7 days</strong></li>\n<li>IV daunorubicin on <strong>days</strong> <strong>1,2,3</strong></li>\n<li>Side effects include neutropenia, sepsis</li>\n</ul>\n</li>\n<li><strong>Post-remission </strong>therapy: \n<ul>\n<li>High dose cytarabine</li>\n<li>Allogenic hematopoeitic stem cell transplant</li>\n</ul>\n</li>\n</ul>\n<p>Novel agents include gemtuzumab ozogamicin, a CD33 monoclonal antibody.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4263",
      "difficulty": "hard"
    },
    {
      "text": "A 60-year-old man came with generalized bone pain, and easy bruisability for the past 6 months. His WBC count was 60,000 cu. mm and bone marrow aspiration revealed the following. Immunohistochemistry was positive for MPO and cytogenetic studies showed presence of t(15:17). What is the preferred treatment regimen?",
      "choices": [
        {
          "id": 1,
          "text": "Cytarabine"
        },
        {
          "id": 2,
          "text": "Arsenic trioxide"
        },
        {
          "id": 3,
          "text": "All transretinoic acid"
        },
        {
          "id": 4,
          "text": "Arsenic trioxide and all transretinoic acid"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The presence of blast cells with numerous Auer rods,&nbsp;<strong>MPO</strong> (myeloperoxidase) positive cells, and&nbsp;<strong>t(15:17)</strong>&nbsp;is diagnostic of acute promyelocytic leukemia (<strong>APL</strong>). The preferred treatment regimen is&nbsp;<strong>arsenic trioxide</strong> and all-trans-retinoic acid (<strong>ATRA</strong>).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a7241b9ca1c4a11b931b0fb6cc49d4fx250x364.JPEG\" alt=\"Explanation Image\"><p>APL is characterized by<strong> t(15; 17)</strong>&nbsp;translocation resulting in the&nbsp;<strong>PML-RAR-alpha</strong> fusion gene (promyelocyte-retinoic acid receptor alpha).&nbsp;It is a <strong>highly curable </strong>subtype of leukemia. The treatment is as follows:</p>\n<ul>\n<li>Induction therapy:\n<ul>\n<li>ATRA + anthracycline (daunorubicin or idarubicin) or cytarabine (<span>OR)</span></li>\n<li>ATRA + arsenic trioxide&nbsp;</li>\n</ul>\n</li>\n<li>Consolidation therapy:\n<ul>\n<li>Post remission anthracycline-based chemotherapy</li>\n</ul>\n</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/673359cd5a6240de8e1730bbd82e271c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4242",
      "difficulty": "medium"
    },
    {
      "text": "An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next?",
      "choices": [
        {
          "id": 1,
          "text": "Cytarabine"
        },
        {
          "id": 2,
          "text": "Dexamethasone"
        },
        {
          "id": 3,
          "text": "Doxorubicin"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario describes a patient of <strong>APL </strong>(acute promyelocytic leukemia) developing <strong>fever, tachypnea</strong>, and<strong> pulmonary infiltrates</strong> while <strong>on medical treatment</strong>. This is suggestive of <strong>APL differentiation syndrome</strong>, an <strong>adverse effect </strong>of <strong>all-trans-retinoic acid (ATRA)</strong>. The management involves glucocorticoids like <strong>dexamethasone</strong>.&nbsp;</p>\n<p>Along with <strong>glucocorticoids</strong>, the other management of APL differentiation syndrome includes <strong>chemotherapy </strong>for <strong>cytoreduction </strong>and <strong>supportive measures</strong>. In <strong>severe </strong>cases,<strong> temporary discontinuation of ATRA</strong> is necessary.</p>\n<p><strong>ATRA</strong> is an oral drug that induces the <strong>differentiation</strong> of leukemic cells bearing the <strong>t(15;17) </strong>chromosomal translocation. While ATRA reduces the incidence of <strong>DIC</strong> associated with <strong>cytarabine</strong> and <strong>daunorubicin</strong> used earlier in APL, it can cause <strong>APL differentiation syndrome</strong> due to the <strong>adhesion </strong>of differentiated neoplastic cells to the <strong>pulmonary vasculature endothelium</strong>.</p>\n<p>In <strong>low-risk APL </strong>patients with a low leukocyte count at presentation, a combination of <strong>ATRA </strong>and <strong>arsenic trioxide (ATO)</strong> has been found to be superior and is the current standard of care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1143",
      "difficulty": "easy"
    },
    {
      "text": "A 47-year-old man with a diagnosis of acute myeloid leukemia with a blood type O negative blood group presents to the transplant clinic to discuss proceeding with an allogeneic stem cell transplant. Which of the following would be an optimal donor?",
      "choices": [
        {
          "id": 1,
          "text": "His identical twin brother"
        },
        {
          "id": 2,
          "text": "Umbilical cord transplant"
        },
        {
          "id": 3,
          "text": "His HLA identical 50-year-old brother who is otherwise healthy and is blood type O+"
        },
        {
          "id": 4,
          "text": "An HLA identical matched unrelated donor who is blood type O–"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the case of acute myeloid leukemia (AML), <strong>allogeneic</strong> stem cell transplants are the <strong>treatment of choice</strong>. His<strong> HLA identical 50-year-old brother</strong> who is blood type <strong>O positive</strong> would be the <strong>best choice</strong>.</p>\n<p>Other options:</p>\n<p>Option A: An <strong>identical twin brother</strong> would <strong>not</strong> be the donor of choice. The therapeutic benefit of stem cell transplant in hematological malignancies is due to the <strong>graft-versus-leukemia (GvL)</strong>. Donor T lymphocytes attack malignant hematopoietic stem cells of the recipient that remain after high-dose chemotherapy. Despite having a <strong>low rate of graft versus host disease</strong> (GvHD), stem cells from an identical twin <strong>do not have</strong> a desirable degree of <strong>GvL effect</strong>, leading to <strong>higher</strong> rates of <strong>recurrence</strong> post-transplant.&nbsp;</p>\n<p>Option B: <strong>Autologous</strong> (umbilical cord transplant) is <strong>not recommended</strong> as <strong>higher</strong> rates of <strong>relapse</strong> have been reported.</p>\n<p>Option D: An <strong>HLA identical sibling</strong> is <strong>preferred over</strong> an <strong>unrelated HLA identical donor </strong>because there is a greater chance of matching for <strong>minor histocompatibility complex</strong> (mHC). This <strong>reduces</strong> the risk of <strong>GvHD</strong>. ABO compatibility is also important to consider, but a minor ABO mismatch (Rh mismatch) doesn't have any impact on hemolysis, graft-versus-host disease, or survival.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1700",
      "difficulty": "hard"
    },
    {
      "text": "Individuals in which age group have the highest incidence of T-cell acute lymphoblastic lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "20-25 years"
        },
        {
          "id": 2,
          "text": "1-10  years"
        },
        {
          "id": 3,
          "text": "10-19 years"
        },
        {
          "id": 4,
          "text": "26-30 years"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The highest incidence of <strong>T-ALL</strong> (T-cell acute lymphoblastic lymphoma) is at <strong>10-19 years </strong>(adolescence) when the thymus reaches the maximum size.</p>\n<p>On the other hand, <strong>B-ALL</strong> which is more common has a peak incidence at <strong>3 years</strong> (1-10 years). At this age, the number of normal bone marrow pre-B cells (the cell of origin) is at its greatest.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2017",
      "difficulty": "medium"
    },
    {
      "text": "Children with Down's syndrome are at an increased risk of developing all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Acute lymphoid leukemia"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 3,
          "text": "Transient myeloproliferative disorder"
        },
        {
          "id": 4,
          "text": "Myelodysplastic disorder"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Down's syndrome</strong> is not associated with myelodysplastic disorder. These patients are at increased risk of developing the following conditions:</p>\n<ul>\n<li>Acute lymphoid leukemia (ALL) - most commonly <strong>B-cell ALL</strong></li>\n<li>Acute myeloid leukemia (<strong>AML</strong>) - most commonly&nbsp;<strong>M7/megakaryoblastic&nbsp;</strong>subtype</li>\n<li>Transient myeloproliferative disorder:\n<ul>\n<li>Associated with <strong>GATA1</strong> mutations.</li>\n<li>Seen in&nbsp;10% of neonates, resolves in&nbsp;first 3 months of life</li>\n<li>Require close follow-up as 20-30% may develop AML by 3 years of life</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4269",
      "difficulty": "medium"
    },
    {
      "text": "An 8-year-old boy was brought with fever, weight loss,  and easy bruisability. Initial examination revealed severe pallor and significant lymphadenopathy. Peripheral smear revealed the following cells, which were also seen on bone marrow studies. Further investigations revealed CD10+ cells. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "T-cell ALL"
        },
        {
          "id": 2,
          "text": "Pro B-cell ALL"
        },
        {
          "id": 3,
          "text": "Pre B-cell ALL"
        },
        {
          "id": 4,
          "text": "Mature B-cell ALL"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario and image showing <strong>blast cells</strong> in a <strong>young</strong> child are suggestive of acute lymphoblastic leukemia (<strong>ALL</strong>). The presence of <strong>CD10</strong> is diagnostic of <strong>pre-B-cell</strong> ALL.</p>\n<p><strong>CD10 </strong>is also called the common ALL antigen (<strong>CALLA</strong>). It is the specific immunohistochemical marker for <strong>pre-B cell ALL</strong>. This is the most common type of ALL and is associated with a <strong>good prognosis</strong>. However, CD10 is negative in infantile leukemia, which is associated with translocation (4;11).</p>\n<p>The <strong>immunohistochemistry</strong> of ALL is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>CD marker</td>\n</tr>\n<tr>\n<td>pro-B cell</td>\n<td><strong>CD34</strong>, <strong>CD19</strong>, CD79a</td>\n</tr>\n<tr>\n<td>pre- B cell</td>\n<td>CD19, CD79a, <strong>CD10</strong>, Tdt, Cytoplasmic Ig</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CD19, CD79a,CD20, CD21,CD22, Surface IgM and D</td>\n</tr>\n<tr>\n<td>T cell</td>\n<td>CD 2,3,4,5,6,<strong>7</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Other abnormalities in ALL include:</p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td>Good prognosis</td>\n<td>Bad prognosis</td>\n</tr>\n<tr>\n<td>Cytogenic</td>\n<td>t(12,21)</td>\n<td>\n<p>t(9,22), t(4,11)</p>\n<p>Burkitt lymphoma-associated ALL / ALL-L3 - t(2,8) , t(8,14), t(8,22)</p>\n</td>\n</tr>\n<tr>\n<td>Molecular</td>\n<td>\n<p>Hyperdiploidy</p>\n<p>HOX</p>\n<p>NOTCH 1 mutations</p>\n</td>\n<td>\n<p>Hypodiploidy</p>\n<p> </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ec64327e878d43ca8fea3da8142db3eb.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4267",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following indicate a good prognosis in children diagnosed with acute lymphoblastic leukemia?<div class='question-desc-html'><ol>\n<li>Age &lt; 1 year</li>\n<li>Mild hepatosplenomegaly</li>\n<li>Hyperdiploidy</li>\n<li>Female sex</li>\n<li>WBC count &lt; 50,000 per mm<sup>3</sup></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 3"
        },
        {
          "id": 3,
          "text": "2, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In children with <strong>ALL</strong>, a <strong>good prognosis</strong> is indicated by <strong>low WBC</strong> count, <strong>female</strong> sex, and <strong>hyperdiploidy</strong>.</p>\n<p>Other abnormalities in ALL include:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Good prognosis</td>\n<td>Bad prognosis</td>\n</tr>\n<tr>\n<td>Cytogenic</td>\n<td>t(12,21)</td>\n<td>\n<p>t(9,22),&nbsp;t(4,11)</p>\n<p>Burkitt lymphoma-associated ALL / ALL-L3 -&nbsp;t(2,8) , t(8,14), t(8,22)</p>\n</td>\n</tr>\n<tr>\n<td>Molecular</td>\n<td>\n<p>Hyperdiploidy</p>\n<p>NOTCH 1</p>\n<p>HOX</p>\n</td>\n<td>Hypodiploidy</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Prognostic factors in ALL</h3><p>Prognostic factors in ALL</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Prognostic factors</strong></td>\n<td><strong>Good</strong></td>\n<td><strong>Bad</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>2-9 years</td>\n<td>&lt;1 year or &gt;10 years</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>Female</td>\n<td>Male</td>\n</tr>\n<tr>\n<td>Race</td>\n<td>White</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>CNS leukemia</td>\n<td>Absent</td>\n<td>Overt</td>\n</tr>\n<tr>\n<td>Hepatosplenomegaly, Lymphadenopathy</td>\n<td>Absent</td>\n<td>Massive</td>\n</tr>\n<tr>\n<td>Mediastinal mass</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Testicular involvement</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>WBC count</td>\n<td>&lt;50,000/mm<sup>3</sup></td>\n<td>&gt;50,000/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td>FAB Type</td>\n<td>L1</td>\n<td>L2,L3</td>\n</tr>\n<tr>\n<td>Cytogenetics</td>\n<td>Hyperdiploidy</td>\n<td>Hypodiploidy</td>\n</tr>\n<tr>\n<td>Immunophenotype</td>\n<td>B-cell, early pre-B</td>\n<td>T cell</td>\n</tr>\n<tr>\n<td>Translocation</td>\n<td>T(12,21),Notch 1,HOX 11</td>\n<td>t(9,22),t(4,11)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4271",
      "difficulty": "medium"
    },
    {
      "text": "A 3-year-old boy with Down's syndrome was brought with recurrent infections and bruising over his legs. Further workup was diagnostic of acute lymphoblastic leukemia and he was started on chemotherapy. Which of the following must be added on to prevent metastases to the central nervous system?",
      "choices": [
        {
          "id": 1,
          "text": "L-Asparginase"
        },
        {
          "id": 2,
          "text": "Prednisolone"
        },
        {
          "id": 3,
          "text": "Cytarabine"
        },
        {
          "id": 4,
          "text": "Methotrextate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Intrathecal methotrexate</strong> is used for <strong>CNS prophylaxis</strong> in acute lymphoblastic leukemia (ALL).&nbsp;It is essential in this condition as nearly 1/3 of patients develop CNS involvement at relapse without prophylactic therapy.</p>\n<p>The treatment of ALL is as follows:</p>\n<p><strong>Induction (4 weeks):</strong></p>\n<ul>\n<li>L-Asparaginase:\n<ul>\n<li>Single-dose</li>\n<li>Side effects - pancreatitis, thrombosis</li>\n</ul>\n</li>\n<li>Vincristine:\n<ul>\n<li>Weekly</li>\n<li>Side effects - neuropathy, SIADH</li>\n</ul>\n</li>\n<li>Prednisolone</li>\n</ul>\n<p><strong>Consolidation:</strong> Intrathecal methotrexate</p>\n<p><strong>Maintenance (</strong><strong>24-36 months):</strong></p>\n<ul>\n<li>6-Mercaptopurine</li>\n<li>Methotrexate</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2218",
      "difficulty": "medium"
    }
  ]
}